According to the disclosure documents of HKEX on September 3,$TENCENT (00700.HK)$,$HSBC HOLDINGS (00005.HK)$And so on to repurchase shares.
Please use your Futubull account to access the feature.$TENCENT (00700.HK)$On September 2, a buyback of 2.65 million ordinary shares was made, involving an amount of HKD 1.003 billion, with a buyback price ranging from HKD 383.2 to HKD 376.6 per share.
Since the share buyback authorization resolution, the cumulative number of repurchased securities is 0.134 billion shares, accounting for 1.417% of the number of issued shares at the time of the ordinary resolution.
Repurchased 3.394 million ordinary shares on May 31, involving an amount of HKD234 million, with a repurchase price per share ranging from HKD69.1 to HKD68.55.$HSBC HOLDINGS (00005.HK)$On August 30, 4.586 million ordinary shares were repurchased, involving an amount of 0.315 billion Hong Kong dollars, with a repurchase price per share ranging from 68.9 Hong Kong dollars to 67.95 Hong Kong dollars.
Repurchased 1 million ordinary shares on June 3, involving an amount of HKD60.6193 million, with a repurchase price per share ranging from HKD61.15 to HKD59.8.$AIA (01299.HK)$On September 2, 1.11 million ordinary shares were repurchased, involving an amount of 60.9982 million Hong Kong dollars, with a repurchase price per share ranging from 55.65 Hong Kong dollars to 54.5 Hong Kong dollars.
Since the share buyback authorization resolution, the cumulative number of repurchased securities is 0.274 billion shares, accounting for 2.437% of the number of issued shares at the time of the ordinary resolution.
Asymchem Laboratories (06821.HK)$BABA-W (09988.HK)$On August 30, the company repurchased 5.7592 million shares of common stock, involving an amount of 59.9767 million US dollars, with a repurchase price per share ranging from 10.58 US dollars to 10.33 US dollars.
Since the share buyback authorization resolution, the total number of securities repurchased is 35.197 million shares, accounting for 0.18% of the number of shares issued at the time of the ordinary resolution.
Repurchased 2.8 million weighted voting right shares on June 3, involving an amount of HKD50.0474 million, with a repurchase price per share ranging from HKD17.94 to HKD17.82.$WUXI BIO (02269.HK)$On September 2, the company repurchased 5.48 million shares of common stock, involving an amount of 59.8116 million Hong Kong dollars, with a repurchase price per share ranging from 10.98 Hong Kong dollars to 10.82 Hong Kong dollars.
Since the share buyback authorization resolution, the total number of securities repurchased is 5.48 million shares, accounting for 0.132% of the number of shares issued at the time of the ordinary resolution.
Details of share buybacks by listed companies can be found in the figure below:
What is share buyback?
Share buyback refers to a behavior of listed companies using cash to repurchase a certain amount of outstanding shares on the stock market. After the share buyback, the company can cancel the repurchased shares. This will reduce the number of outstanding shares in circulation, thus achieving positive effects such as market cap management, stock-based incentive, and stable stock price.